Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 23Breast 12Genitourinary 11Thoracic 7Head & Neck 6Dermatologic 6Gynecologic 4Other 3CNS 3Lymphoid 2Other hematologic neoplasm 1

Conditions

Neurofibromatoses 1Neoplasms 1Hydrocephalus 1Headache 1Glioblastoma 1Epilepsy 1Brain Neoplasms 1Abdominal Neoplasms 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lidocaine × CNS × Clear all
NCT04716699 2026-03-10

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

University of California, Davis

Phase 1 Completed
12 enrolled
CNS

Glioblastoma

NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn
CNS

Brain Neoplasms

NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡